Literature DB >> 25902918

A new VETC in hepatocellular carcinoma metastasis.

Kaisa L Hanley1, Gen-Sheng Feng1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25902918      PMCID： PMC5330284          DOI： 10.1002/hep.27860

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  8 in total

Review 1.  Hepatocellular carcinoma.

Authors:  Hashem B El-Serag
Journal:  N Engl J Med       Date:  2011-09-22       Impact factor: 91.245

Review 2.  VEGF and angiopoietin signaling in tumor angiogenesis and metastasis.

Authors:  Pipsa Saharinen; Lauri Eklund; Kristina Pulkki; Petri Bono; Kari Alitalo
Journal:  Trends Mol Med       Date:  2011-04-12       Impact factor: 11.951

3.  Endothelium-coated tumor clusters are associated with poor prognosis and micrometastasis of hepatocellular carcinoma after resection.

Authors:  Tong Ding; Jing Xu; Ying Zhang; Rong-Ping Guo; Wen-Chao Wu; Shao-Dan Zhang; Chao-Nan Qian; Limin Zheng
Journal:  Cancer       Date:  2011-04-08       Impact factor: 6.860

4.  A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner.

Authors:  Jian-Hong Fang; Hui-Chao Zhou; Chong Zhang; Li-Ru Shang; Lei Zhang; Jing Xu; Limin Zheng; Yunfei Yuan; Rong-Ping Guo; Wei-Hua Jia; Jing-Ping Yun; Min-Shan Chen; Yaojun Zhang; Shi-Mei Zhuang
Journal:  Hepatology       Date:  2015-04-22       Impact factor: 17.425

Review 5.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

6.  Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.

Authors:  Suguru Yamada; Norio Okumura; Lan Wei; Bryan C Fuchs; Tsutomu Fujii; Hiroyuki Sugimoto; Shuji Nomoto; Shin Takeda; Kenneth K Tanabe; Yasuhiro Kodera
Journal:  Ann Surg Oncol       Date:  2014-05-15       Impact factor: 5.344

7.  Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells.

Authors:  Roberta Mazzieri; Ferdinando Pucci; Davide Moi; Erika Zonari; Anna Ranghetti; Alvise Berti; Letterio S Politi; Bernhard Gentner; Jeffrey L Brown; Luigi Naldini; Michele De Palma
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

8.  TGF-β isoforms induce EMT independent migration of ovarian cancer cells.

Authors:  Jingfang Gao; Yihong Zhu; Mikael Nilsson; Karin Sundfeldt
Journal:  Cancer Cell Int       Date:  2014-09-09       Impact factor: 5.722
  8 in total
  1 in total

1.  SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo.

Authors:  Chi-Neu Tsai; Shu-Chuan Yu; Chao-Wei Lee; Jong-Hwei Su Pang; Chun-Hsin Wu; Sey-En Lin; Yi-Hsiu Chung; Chia-Lung Tsai; Sen-Yung Hsieh; Ming-Chin Yu
Journal:  Oncogene       Date:  2020-05-13       Impact factor: 9.867
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.